Table 2 One-year survival analysis after lung cancer diagnosis
Univariate | Multivariate* | ||||
|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | ||
Age | < 55 | – | – | – | – |
55–65 | 0.91 (0.75–1.10) | 0.341 | 0.93 (0.77–1.26) | 0.450 | |
65–75 | 1.00 (0.83–1.21) | 0.988 | 1.05 (0.87–1.27) | 0.609 | |
≥ 75 | 1.75 (1.46–2.09) | < 0.0001 | 2.02 (1.69–2.42) | < 0.0001 | |
Gender | Male | – | – | – | – |
Female | 0.89 (0.78–1.01) | 0.061 | 0.85 (0.75–0.97) | 0.013 | |
Metastasis | 3.46 (2.77–4.32) | < 0.0001 | 4.39 (3.83–5.03) | < 0.0001 | |
PE after cancer diagnosis | 2.43 (1.94–3.06) | < 0.0001 | 1.53 (1.20–1.95) | 0.0006 | |
DVT after cancer diagnosis | 1.60 (1.29–1.97) | < 0.0001 | 1.26 (1.01–1.57) | 0.043 | |
Major bleeding | 2.17 (1.86–2.54) | < 0.0001 | 1.81 (1.54–2.12) | < 0.0001 | |